Development of an in vitro model for cysteine dioxygenase expression in the brain

Cell Biology and Toxicology

Volumn 16, Issue 4, 2000, Pages 243-255

  Qusti, S ^a   Parsons, R B ^b   Abouglila, K D H ^b   Waring, R H ^a   Williams, A C ^a   Ramsden, D B ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Cell culture; Cysteine dioxygenase; In vitro brain model; Parkinson's disease; Tumor necrosis factor

Indexed keywords

CYSTEINE; CYSTEINE DIOXYGENASE; MESSENGER RNA; OXYGENASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; DEGENERATIVE DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ASTROCYTOMA; BASE SEQUENCE; BRAIN; BRAIN NEOPLASMS; CELL SURVIVAL; CEREBELLAR NEOPLASMS; CYSTEINE DIOXYGENASE; DIOXYGENASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOBLASTOMA; HUMANS; MALE; MEDULLOBLASTOMA; MODELS, ANIMAL; MODELS, NEUROLOGICAL; MOLECULAR SEQUENCE DATA; NEURONS; OXYGENASES; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; ILEX COOKII;

EID: 0033777675     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007634110983     Document Type: Article

References (53)

1. Oxygen free radicals and Parkinson's disease
2. Marked increase of cysteine levels in many regions of the brain after administration of 2-oxothiazolidine-4-carboxylate
3. Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: A double-blind placebo-controlled trial
4. Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis
5. Effects of non-sulfur and sulfur amino acids on the regulation of hepatic enzymes of cysteine metabolism
6. L-Cysteinesulphinic acid as an endogenous agonist of a novel metabotropic receptor coupled to stimulation of phospholipase D activity
7. A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding
8. Effects of ethanol feeding and withdrawal on plasma glutathione elimination in the rat
9. The effect of dietary cysteine levels upon cysteine metabolism in rats
10. Independent and combined actions of interleukin-1β, tumour necrosis factor α and glucagon on amino acid metabolism in the isolated perfused rat liver
11. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease
12. The role of excitotoxicity in neurodegenerative disease: Implications for therapy
13. A spectrophotometric method for the direct determination of cysteine in the presence of other naturally occurring amino acids
14. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
15. Immaturity of the enzyme activity and the response to inducers of rat liver cysteine dioxygenase during rat development
16. Isolation and characterisation of a cDNA for rat liver cysteine dioxygenase
17. Regulatory role of cysteine dioxgyenase in cerebral biosynthesis of taurine. Analysis using cerebellum from 3-acetylpyridine treated rats
18. Chromosomal localisation of genes encoding for human and mouse liver cytosolic cysteine dioxygenase
19. Dietary control of cysteine dioxygenase in rat liver
20. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
21. Irreversible inhibition of mitochondiral complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxylic acid (DHBT-1): A putatuve nigral endotoxin relevant to Parkinson's disease
22. Human cysteine dioxygenase type-I: Primary structure derived from base sequencing of cDNA
23. Effect of morphine on cysteine oxidase activity in the rat brain and reproductive tracts of rats
24. Carbamate formation and the neurotoxicity of L-α-amino acids
25. An introduction to the free radical hypothesis of Parkinson's disease
26. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine
27. L-Cysteine, a bicarbonate-sensitive excitotoxin
28. Excitotoxicity of L-DOPA and 6-OH-DOPA: Implications for Parkinson's and Huntington's diseases
29. Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants
30. Cytokines and metabolic dysfunction after severe head injury
31. Toxicity of cysteine and cysteinesulphinic acid to human neuronal cell-lines
32. Hepatic localisation of rat cysteine dioxygenase
33. Cysteine dioxygenase: Regional expression of activity in rat brain
34. Toxicity of sulphur-containing compounds to neuronal cell-lines
35. Hallervorden-Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globul pallidus
36. Spontaneous exidation of methionine: Effect on the quantification of plasma methionine levels
37. Amino acid absorption and production of pancreatic hormones in non-anaesthetized pigs after duodenal infusions of a milk enzymic hydrosylate or of free amino acids
38. Purification and some properties of rat liver cysteine oxidase (cysteine dioxygenase)
39. Mitochondrial complex-I deficiency in Parkinson's disease
40. Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors
41. The acute effects of TNF-α on the isolated perfused rat liver
42. The enzymic oxidation of cysteine to cysteinesulphinate in rat liver
43. Drug metabolism in Parkinson's disease
44. Effects of tumour necrosis factor α on skeletal muscle amino acid metabolism studied in vivo
45. Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurones observed in Parkinson's disease
46. Effect of folic acid and betaine on fasting and postmethionine-loading plasma homocysteine and methionine levels in chronic haemodialysis patients
47. The metabolism of glutathione studied with isotopic glycine
48. The acute metabolic effects of tumour necrosis factor administration in humans
49. Homocystinuria due to cystathionine beta-synthase deficiency - The effects of betaine treatment in pyridoxine-responsive patients
50. The stabilising protein, protein-A, of cysteine dioxygenase
51. Induction and activation of cysteine oxidase in rat liver I. The effects of cysteine, hydrocortisone and nicotinamide injections on hepatic cysteine oxidase and tyrosine transaminase activities of intact and adrenalectomised rats
52. Rat liver cysteine dioxygenase (cysteine oxidase). Further purification, characterisation and analysis of the activation and inactivation
53. Hepatic mitochondrial enzyme activity and serum amino acid composition in rats treated with tumour necrosis factor